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Background: Human T cell leukemia virus type 1 (HTLV-1) Tax is a potent activator of viral and cellular gene
expression that interacts with a number of cellular proteins. Many reports show that Tax is capable of regulating
cell cycle progression and apoptosis both positively and negatively. However, it still remains to understand why the
Tax oncoprotein induces cell cycle arrest and apoptosis, or whether Tax-induced apoptosis is dependent upon its
ability to induce G1 arrest. The present study used time-lapse imaging to explore the spatiotemporal patterns of cell
cycle dynamics in Tax-expressing HeLa cells containing the fluorescent ubiquitination-based cell cycle indicator,
Fucci2. A large-scale host cell gene profiling approach was also used to identify the genes involved in
Tax-mediated cell signaling events related to cellular proliferation and apoptosis.
Results: Tax-expressing apoptotic cells showed a rounded morphology and detached from the culture dish after
cell cycle arrest at the G1 phase. Thus, it appears that Tax induces apoptosis through pathways identical to those
involved in G1 arrest. To elucidate the mechanism(s) by which Tax induces cell cycle arrest and apoptosis,
regulation of host cellular genes by Tax was analyzed using a microarray containing approximately 18,400 human
mRNA transcripts. Seventeen genes related to cell cycle regulation were identified as being up or
downregulated> 2.0-fold in Tax-expressing cells. Several genes, including SMAD3, JUN, GADD45B, DUSP1 and IL8,
were involved in cellular proliferation, responses to cellular stress and DNA damage, or inflammation and immune
responses. Additionally, 23 pro- and anti-apoptotic genes were deregulated by Tax, including TNFAIP3, TNFRS9,
BIRC3 and IL6. Furthermore, the kinetics of IL8, SMAD3, CDKN1A, GADD45A, GADD45B and IL6 expression were
altered following the induction of Tax, and correlated closely with the morphological changes observed by
time-lapse imaging.
Conclusions: Taken together, the results of this study permit a greater understanding of the biological events
affected by HTLV-1 Tax, particularly the regulation of cellular proliferation and apoptosis. Importantly, this study is
the first to demonstrate the dynamics of morphological changes during Tax-induced apoptosis after cell cycle arrest
at the G1 phase.* Correspondence: aida@riken.jp
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Human T cell leukemia virus type 1 (HTLV-1) causes
adult T cell leukemia (ATL), a severe and fatal lympho-
proliferative disease of helper T cells [1], and a separate
neurodegenerative disease called tropical spastic para-
paresis/HTLV-1-associated myelopathy (TSP/HAM) [2].
HTLV-1 encodes a 40 kDa regulatory protein, Tax,
which is necessary and sufficient for cellular transform-
ation and is, therefore, considered to be the viral onco-
protein. Tax is a potent activator of both viral and
cellular gene expression, and the oncogenic potential of
Tax is thought to depend on its ability to alter the ex-
pression of cellular genes involved in cell growth and
proliferation, and its direct interactions with cell cycle
regulators [3,4]. Tax-mediated transcriptional activation
of cellular gene expression requires direct contact with
components of the cyclic AMP-response element bind-
ing protein (CREB), nuclear factor-κB (NF-κB), and the
serum response factor (SRF) signaling pathways [5].
Moreover, Tax is thought to be involved in other cellular
processes including DNA repair, cell cycle progression,
and apoptosis [6,7].
Tax stimulates cell growth via cell cycle dysregulation
[3,4,7]. A major mitogenic activity of Tax is stimulation
of the G1-to-S-phase transition [8-12], and several differ-
ent mechanisms have been proposed to explain the dys-
regulation of the G1 phase and the accelerated
progression into S phase. In mammalian cells, G1 pro-
gression is controlled by the sequential activation of the
cyclin-dependent kinases (Cdks) Cdk4, Cdk6, and Cdk2.
Activation of these Cdks by Tax leads to hyperphosphor-
ylation of Retinoblastoma (Rb) and the liberation of E2F,
which is essential for cell cycle progression [12,13]. Tax
interacts with cyclins D1, D2, and D3, but not with
Cdk1 or Cdk2 [11,14-16]. By binding to cyclins, Tax sta-
bilizes the cyclin D/Cdk complex, thereby enhancing its
kinase activity and leading to the hyperphosphorylation
of Rb. Moreover, Tax activates the transcription of cyclin
D1 and D2 [17,18] by deregulating the NF-κB pathway
[18,19]. By contrast, there is evidence that Tax induces
cell cycle arrest at the G1 phase [20]. HTLV-1 infection
and Tax expression in human cells have been observed
to induce cell cycle arrest at the G1 phase by inducing
p27/kip1 and p21/waf1 [20], and the sharp rise in p27
induced by Tax is often associated with premature acti-
vation of the anaphase-promoting complex (APC) [21].
Indeed, cells infected with HTLV-1 expressing wild-type
Tax arrest at the G1/S boundary when subjected to cellu-
lar stress [22,23].
Interestingly, Tax induces apoptosis in a variety of sys-
tems [24-26], consistent with its ability to inhibit DNA
repair. Indeed, HTLV-1-infected cells undergo increased
apoptosis upon cellular stress [22-28]; however, other
reports show that Tax inhibits apoptosis [29-31],supporting its role as a transforming protein and an in-
ducer of T cell proliferation. Therefore, it seems likely
that Tax is capable of stimulating both pro- and anti-
apoptotic pathways.
Tax regulates cell cycle progression and apoptosis both
positively and negatively; however, the molecular mechan-
ism(s) underlying the regulation of these processes by Tax
remain obscure. In this study, we examined the regulation
of cell cycle progression and apoptosis by Tax and demon-
strated the following: (i) a high level of transient Tax ex-
pression arrests the cell cycle at the G1 phase and induces
apoptosis in HeLa cells; (ii) based on a microarray con-
taining approximately 18,400 human mRNA transcripts,
genes related to cell cycle progression and apoptosis were
deregulated by Tax in HeLa cells; (iii) time-lapse imaging
of a fluorescent ubiquitination-based cell cycle indicator
(Fucci2) in HeLa cells allows for dual-color imaging and
can be used to distinguish between live cells in the G1 and
S/G2/M phases. Using this system for the in vivo analysis
of the spatial and temporal patterns of cell cycle dynamics
[32,33], we demonstrated that Tax-expressing cells arrest
in the G1 phase of the cell cycle and proceeded to apop-
tosis; and (iv) we found that Tax-induced changes in the
expression of genes related to cell cycle regulation and
apoptosis correlated well with the morphological changes
observed in the cells.
Results
Tax induces cell cycle arrest and apoptosis in transfected
HeLa cells
To examine whether Tax induces cell cycle arrest at the
G1 phase and promotes apoptosis in HeLa cells,
chimeric Tax carrying a Flag tag at the carboxyl terminus
was transfected into HeLa cells. At 24 h post transfec-
tion, the expression of Tax protein was assessed by
immunoblot analysis of cell extracts using the monoclo-
nal antibody (MAb) M2, which recognizes the Flag tag
(Figure 1A). A single band with an apparent molecular
mass consistent with the predicted sequences was
observed. As shown in Figure 1B, Tax was detected in
both the nucleus and cytoplasm of transfected HeLa
cells. This result correlates well with previous studies in-
dicating that Tax is able to shuttle between the nucleus
and the cytoplasm but predominantly localizes in the
nucleus [34]. As shown in Figure 1C, Tax showed con-
siderable transactivation activity toward the HTLV-1 en-
hancer, indicating that chimeric Tax with a C-terminal
Flag tag was fully functional.
Next, the cell cycle distribution of Tax-expressing
HeLa cells was analyzed. Cells were stained with propi-
dium iodide (PI) and analyzed by flow cytometry 48 h
after co-transfection with the Tax expression vector or
the control vector and a green fluorescence protein











































































Figure 1 Tax induces G1 cell cycle arrest and apoptosis. HeLa cells were transiently transfected with a pCAGGS-Tax Flag-tagged vector or the
control pCAGGS vector (A, B and E) together with either the reporter plasmid pGV-HL21 (HTLV-1 enhancer) and the reference plasmid pRL-SV40
(C), or the GFP expression vector pEGFP-NI (D and G) or the pSV-β-galactosidase vector (F). (A) At 24 h post-transfection, cells were lysed and
subjected to immunoblot analysis with an anti-Flag MAb and an anti-actin MAb (as a control). (B) At 24 h post-transfection, cells were fixed,
permeabilized, and immunostained with an anti-Flag MAb followed by an Alexa 488-conjugated anti-mouse IgG antibody. Cells were analyzed by
confocal laser scanning microscopy (Olympus FV1000). (C) At 48 h after transfection, cells were recovered and the activities of firefly and Renilla
luciferases were measured in lysates. For each sample, the firefly luciferase activity (pGV-HL21) was normalized by reference to Renilla luciferase
activity (pRL-SV40). (D) At 48 h post-transfection, cells were fixed and stained with propidium iodide for the analysis of DNA content. GFP-positive
cells were analyzed by flow cytometry using Cell Quest for acquisition and ModFit LT. The peaks of the cells at G1 and G2/M phase are indicated.
(E) At 48 h post-transfection, cells were collected, lysed, and analyzed for phosphorylation of Rb by immunoblotting with an anti-Rb MAb using
an anti-actin MAb as a control. ppRb, hyperphosphorylated forms of Rb; pRb, hypo- and unphosphorylated forms of Rb. (F) At 48 h post-
transfection, cells were collected, lysed, β-galactosidase activity was measured. Caspase-3 activity was measured in the cell lysates with an equal
amount of β-galactosidase activity. Each of the columns and its associated error bar represent the mean± standard deviation (SD) of results from
four different experiments. The asterisk (*) represents a p-value of< 0.01. (G) At 48 h post-transfection, cells were stained with PE-Annexin V and
7-AAD to identify apoptotic cells. GFP was used as a reporter to discriminate between transfected and untransfected cells. The percentage of
Annexin V-positive and 7-AAD-negative cells relative to GFP-positive cells indicates the level of apoptosis.
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from one of three independent experiments. As shown in
Figure 1D, flow cytometry analysis revealed that there was
a marked increase in the percentage of cells in the G1
phase in cells transfected with Tax (approximately
92%±4.5%) compared with cells transfected with the con-
trol vector (approximately 58%±4.3%), strongly indicating
that G1 cell cycle arrest was induced in Tax-expressing
cells (p< 0.001). To confirm this result, total cell extracts
were collected 48 h post-transfection and the phosphoryl-
ation status of Rb was determined by immunoblotting
with an anti-Rb MAb, which detects all forms of Rb. The
phosphorylation status of Rb serves as a marker of cells in
the G0/G1 phase of the cell cycle, since Rb is progressively
phosphorylated throughout the G1 phase and is hyperpho-
sphorylated upon transition into the S phase [35]. As
shown in Figure 1E, hyperphosphorylated form (ppRb)
migrated more slowly than the hypo- and unphosphory-
lated forms (pRb). The majority of Rb was hyperpho-
sphorylated (upper major band) in cells transfected with
the control vector; however, a decrease in the level of
hyperphosphorylated form (ppRb) and an increase in the
levels of hypo- and/or unphosphorylated form (pRb) were
observed in extracts prepared from Tax-expressing cells.
These results confirmed that Tax prevents hyperpho-
sphorylation of Rb and blocks cell cycle progression at the
G1 phase.
To analyze whether Tax induced apoptosis, HeLa cells
were transfected with a Tax expression vector or a con-
trol vector, and the activity of caspase-3, which plays an
essential role in apoptosis, was measured. Caspase-3 ac-
tivity was significantly higher in Tax-expressing cells
than in control cells (Figure 1F; p< 0.01). Next, the
apoptotic activity of Tax was further quantified using
flow cytometry by co-staining transfected cells with
phycoerythrin (PE)-Annexin V and 7-amino-actinomycin
D (7-AAD) (Figure 1G). A prominent event in early
apoptosis is the exposure of phosphatidylserine (PS) on
the outer leaflet of the cell membrane. Cell surface-
exposed PS is specifically detected by PE-Annexin V,
and during the late stages of apoptosis or necrosis, cell
membrane integrity is lost, allowing entry of the DNA-
binding dye 7-AAD. The population of Annexin V-
positive and 7-AAD-negative apoptotic cells was much
higher in Tax-expressing cells (19.9%) than in cells trans-
fected with the control vector (3.5%). Because the same
trends were observed for caspase-3 activity (Figure 1F)
and apoptotic activity (Figure 1G), it was concluded that
Tax induces apoptosis in HeLa cells.
Large-scale expression profiling of cellular genes after
transfection with tax
To analyze the mechanism(s) underlying the regulation
of cell cycle progression and apoptosis by Tax, totalRNA was isolated from HeLa cells transfected with
Tax or a control vector, and each RNA sample was sub-
jected to microarray analysis (GEO accession number
GSE34750). Data sets were analyzed using GeneSpring
GX 11.0 software for gene expression, clustering, gene
ontology, and significant signaling pathways. Using
microarrays containing approximately 18,400 mRNA
transcripts, 342 genes were identified (269 upregulated
and 73 downregulated) that showed statistically signifi-
cant levels of differential regulation by Tax (p< 0.05)
(Tables 1 and 2).
The upregulated genes (2-fold or greater) were clus-
tered within functional groups involved in transcription/
translation/RNA processing, signal transduction, the im-
mune response, apoptosis, cell cycle regulation, and cell
growth/proliferation (Table 1). In addition, a number of
molecules involved in the immune response were signifi-
cantly downregulated by Tax (Table 2).
Tax induces the expression of genes related to cell cycle
progression and apoptosis
It was hypothesized that changes in gene expression may
provide valuable information about the dysregulation of
cell cycle progression induced by Tax and about how
Tax might affect the genes relevant to this process. As
shown in Figure 2A, of 17 genes related to cell cycle
progression that were regulated by Tax, five were down-
regulated and 12 were upregulated (fold change> 2.0;
p< 0.05). Genes associated with mitosis (CENPF, SEP11,
and NF2), including the mitotic cell cycle checkpoint
(MAD2L1) and mitotic centrosome separation (KIF11),
were repressed by Tax. By contrast, genes upregulated
by Tax were functionally classified as genes related to
the cell cycle (GADD45A, RGS2, MAP3K8, SESN1,
CDKN1A, CYLD, PLK2, SMAD3, JUN, GADD45B,
DUSP1 and IL8). Many of these genes are also involved
in other processes, such as the response to stress
(GADD45B), the response to DNA damage (GADD45A,
SESN1, CDKN1A), MAP kinase activity (GADD45B,
MAP3K8, DUSP1), cell proliferation (JUN and IL8), and
negative regulation of the cell cycle (CYLD, PLK2 and
SMAD3). Genes such as SMAD3, GADD45B, and
DUSP1 were also identified as having a role in apoptosis,
and IL8 is additionally involved in inflammation and the
immune response.
The microarray results for genes related to cell cycle
progression were validated by performing real-time
quantitative reverse transcription polymerase chain reac-
tion (qRT-PCR) on five upregulated genes (Figure 2B).
The results of the qRT-PCR agreed with those obtained
by microarray analysis.
Next, Tax-regulated genes related to apoptosis were
identified (Figure 2C). The microarray results revealed
that 21 pro- or anti-apoptotic genes were regulated by
Table 1 Genes upregulated by Tax (fold change≥2.0, p< 0.05)
Gene symbol Gene description Gene ID Fold change
Transcription/Translation/RNA processing
FOXF1 forkhead box F1 2294 2.0
NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 4791 2.0
NR6A1 nuclear receptor subfamily 6, group A, member 1 2649 2.0
CEBPD CCAAT/enhancer binding protein (C/EBP), delta 1052 2.1
ETV5 ets variant 5 2119 2.1
FST follistatin 10468 2.2
KLF6 Kruppel-like factor 6 1316 2.2
CEBPD CCAAT/enhancer binding protein (C/EBP), delta 1052 2.3
EGR3 early growth response 3 1960 2.3
SAMD4A sterile alpha motif domain containing 4A 23034 2.3
ELL2 elongation factor, RNA polymerase II, 2 22936 2.4
HIVEP2 human immunodeficiency virus type I enhancer binding protein 2 3097 2.4
MAFB v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) 9935 2.4
FOSL2 FOS-like antigen 2 2355 2.5
ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 3398 2.5
KLF2 Kruppel-like factor 2 (lung) 10365 2.5
RELB v-rel reticuloendotheliosis viral oncogene homolog B 5971 2.5
MAFF v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) 23764 2.8
LARP6 La ribonucleoprotein domain family, member 6 55323 3.1
REL v-rel reticuloendotheliosis viral oncogene homolog (avian) 5966 3.1
FOSB FBJ murine osteosarcoma viral oncogene homolog B 2354 3.2
HES1 hairy and enhancer of split 1 (Drosophila) 3280 3.2
SOD2 superoxide dismutase 2, mitochondrial 6648 3.4
ATF3 activating transcription factor 3 467 3.6
FOSL1 FOS-like antigen 1 8061 4.1
ZFP36 zinc finger protein 36, C3H type, homolog (mouse) 7538 4.2
ZNF331 zinc finger protein 331 55422 4.4
BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 60468 4.4
NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon 4794 4.4
EGR1 early growth response 1 1958 6.2
FOS FBJ murine osteosarcoma viral oncogene homolog 2353 8.4
NR4A2 nuclear receptor subfamily 4, group A, member 2 4929 10.9
Signal Transduction
EDN2 endothelin 2 1907 2.0
EPHA2 EPH receptor A2 1969 2.1
RIT1 Ras-like without CAAX 1 6016 2.1
SH2D3A SH2 domain containing 3A 10045 2.1
KLRC1 killer cell lectin-like receptor subfamily C, member 1///killer cell lectin-like receptor subfamily C, member 2 3821 2.2
PSD4 pleckstrin and Sec7 domain containing 4 23550 2.5
ADM adrenomedullin 133 2.7
GPRC5C G-protein-coupled receptor, family C, group 5, member C 55890 2.7
BDKRB2 bradykinin receptor B2 624 2.8
GDF15 growth differentiation factor 15 9518 3.0
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Table 1 Genes upregulated by Tax (fold change≥2.0, p< 0.05) (Continued)
GPR87 G protein-coupled receptor 87 53836 3.4
RASA4 RAS p21 protein activator 4///RAS p21 protein activator 4 pseudogene 10156 8.8
GEM GTP binding protein overexpressed in skeletal muscle 2669 14.1
GABBR1 gamma-aminobutyric acid (GABA) B receptor, 1///ubiquitin D 10537 24.5
RRAD Ras-related associated with diabetes 6236 115.2
Inflammatory response/Immune response
KLRC1 killer cell lectin-like receptor subfamily C, member 1 3821 2.2
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 5743 2.3
CCL22 chemokine (C-C motif) ligand 22 6367 3.0
IL6R interleukin 6 receptor 3570 3.0
TNIP1 TNFAIP3 interacting protein 1 10318 3.2
EBI3 Epstein-Barr virus induced 3 10148 3.2
IL27RA interleukin 27 receptor, alpha 9466 3.5
TRIM22 tripartite motif-containing 22 10346 3.8
IL32 interleukin 32 9235 3.8
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 7130 4.0
GBP2 guanylate binding protein 2, interferon-inducible 2634 5.2
GBP2 guanylate binding protein 2, interferon-inducible 2634 5.4
CCL19 chemokine (C-C motif) ligand 19 6363 6.2
CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) 2919 11.7
CXCL11 chemokine (C-X-C motif) ligand 11 6373 13.1
CXCL3 chemokine (C-X-C motif) ligand 3 2921 19.1
CCL20 chemokine (C-C motif) ligand 20 6364 20.1
PTX3 pentraxin-related gene, rapidly induced by IL-1 beta 5806 81.1
CXCL2 chemokine (C-X-C motif) ligand 2 2920 87.0
Apoptosis regulation
ZMAT3 zinc finger, matrin type 3 64393 2.0
JMJD6 jumonji domain containing 6 23210 2.0
AEN apoptosis enhancing nuclease 64782 2.1
ADORA2A adenosine A2a receptor 135 2.2
CD70 CD70 molecule 970 2.2
FAS Fas (TNF receptor superfamily, member 6) 355 2.3
BAG3 BCL2-associated athanogene 3 9531 2.4
BIK BCL2-interacting killer (apoptosis-inducing) 638 2.4
BCL6 B-cell CLL/lymphoma 6 604 2.7
TNFRSF1B tumor necrosis factor receptor superfamily, member 1B 7133 3.3
ZC3H12A zinc finger CCCH-type containing 12A 80149 4.1
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 4792 5.2
NR4A1 nuclear receptor subfamily 4, group A, member 1 3164 5.4
IER3 immediate early response 3 8870 5.7
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 7128 6.4
BTG2 BTG family, member 2 7832 7.0
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 3604 8.2
BIRC3 baculoviral IAP repeat-containing 3 330 14.8
IL6 interleukin 6 (interferon, beta 2) 3569 18.0
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Table 1 Genes upregulated by Tax (fold change≥2.0, p< 0.05) (Continued)
Cell cycle regulation
GADD45A growth arrest and DNA-damage-inducible, alpha 1647 2.2
RGS2 regulator of G-protein signaling 2, 24 kDa 5997 2.2
MAP3K8 mitogen-activated protein kinase kinase kinase 8 1326 2.3
SESN1 sestrin 1 27244 2.6
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 1026 2.8
CYLD cylindromatosis (turban tumor syndrome) 1540 2.9
PLK2 polo-like kinase 2 (Drosophila) 10769 3.0
SMAD3 SMAD family member 3 4088 4.4
JUN jun oncogene 3725 4.6
GADD45B growth arrest and DNA-damage-inducible, beta 4616 4.8
DUSP1 dual specificity phosphatase 1 1843 8.5
IL8 interleukin 8 3576 41.7
Regulation of cell growth/Regulation of cell proliferation
ZMAT3 zinc finger, matrin type 3 64393 2.0
CSF1 colony stimulating factor 1 (macrophage) 1435 2.1
FGFR2 fibroblast growth factor receptor 2 2263 2.1
ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 25841 2.4
SOCS2 suppressor of cytokine signaling 2 8835 2.4
PGF placental growth factor 5228 2.6
HBEGF heparin-binding EGF-like growth factor 1839 2.7
LIF leukemia inhibitory factor (cholinergic differentiation factor) 3976 2.9
FGF18 fibroblast growth factor 18 8817 4.9
CCL2 chemokine (C-C motif) ligand 2 6347 6.7
IL11 interleukin 11 3589 7.4
RARRES1 retinoic acid receptor responder (tazarotene induced) 1 5918 7.5
IGFBP1 insulin-like growth factor binding protein 1 3484 32.2
DLGAP4 discs, large (Drosophila) homolog-associated protein 4 22839 2.5
EFNA1 ephrin-A1 1942 2.5
WNT4 wingless-type MMTV integration site family, member 4 54361 9.3
Cell adhesion
LYPD3 LY6/PLAUR domain containing 3 27076 2.0
PDZD2 PDZ domain containing 2 23037 2.1
FERMT2 fermitin family homolog 2 (Drosophila) 10979 2.2
NINJ1 ninjurin 1 4814 2.2
SIRPA signal-regulatory protein alpha 140885 2.2
COL7A1 collagen, type VII, alpha 1 1294 2.3
LAMB3 laminin, beta 3 3914 2.6
CDH5 cadherin 5, type 2 (vascular endothelium) 1003 4.4
CTGF connective tissue growth factor 1490 4.4
SAA1 serum amyloid A1///serum amyloid A2 6288 10.3
ICAM1 intercellular adhesion molecule 1 3383 10.8
Transport
SLC37A1 solute carrier family 37 (glycerol-3-phosphate transporter), member 1 54020 2.0
SLC1A3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 6507 2.2
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Table 1 Genes upregulated by Tax (fold change≥2.0, p< 0.05) (Continued)
C19orf28 chromosome 19 open reading frame 28 126321 2.6
NPTX1 neuronal pentraxin I 4884 2.6
SLC2A6 solute carrier family 2 (facilitated glucose transporter), member 6 11182 3.5
HBA1 hemoglobin, alpha 1 3039 5.4
Metabolic process
HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) 3157 2.0
PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 5742 2.0
IDS iduronate 2-sulfatase 3423 2.2
PI4K2A phosphatidylinositol 4-kinase type 2 alpha 55361 2.2
PLA2G4C phospholipase A2, group IVC (cytosolic, calcium-independent) 8605 2.2
C12orf5 chromosome 12 open reading frame 5 57103 2.3
PANX1 pannexin 1 24145 2.3
ABCA1 ATP-binding cassette, subfamily A (ABC1), member 1 19 2.4
AMPD3 adenosine monophosphate deaminase (isoform E) 272 2.4
SAT1 spermidine/spermine N1-acetyltransferase 1 6303 2.5
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase) 231 2.6
GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type 9245 2.6
PITPNM1 phosphatidylinositol transfer protein, membrane-associated 1 9600 2.6
MICAL2 microtubule-associated monoxygenase, calponin and LIM domain containing 2 9645 3.2
PPAP2B phosphatidic acid phosphatase type 2B 8613 3.2
ARG2 arginase, type II 384 4.1
PTGES prostaglandin E synthase 9536 4.7
GFPT2 glutamine-fructose-6-phosphate transaminase 2 9945 5.0
Phosphorylation/Dephosphorylation
DUSP6 dual specificity phosphatase 6 1848 2.0
FAM129A family with sequence similarity 129, member A 116496 2.3
DUSP13 dual specificity phosphatase 13 51207 2.6
DUSP5 dual specificity phosphatase 5 1847 4.1
PTPRE protein tyrosine phosphatase, receptor type, E 5791 4.1
Response to stress
HSPA2 heat shock 70 kDa protein 2 3306 2.3
HSPA1A heat shock 70 kDa protein 1A 3303 2.9
HSPB8 heat shock 22 kDa protein 8 26353 3.1
HSPB3 heat shock 27 kDa protein 3 8988 4.0
HSPB7 heat shock 27 kDa protein family, member 7 (cardiovascular) 27129 4.0
DNAJB1 DnaJ (Hsp40) homolog, subfamily B, member 1 3337 4.2
HSPA6 heat shock 70 kDa protein 6 3310 7.6
Ubiquitin
ENC1 ectodermal-neural cortex (with BTB-like domain) 8507 2.3
MAP1LC3C microtubule-associated protein 1 light chain 3 gamma 440738 3.4
Others/Unknown
OLR1 oxidized low density lipoprotein (lectin-like) receptor 1 4973 2.0
TRIB1 tribbles homolog 1 (Drosophila) 10221 2.0
UNC13A unc-13 homolog A (C. elegans) 23025 2.0
SNAI1 snail homolog 1 (Drosophila) 6615 2.1
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Table 1 Genes upregulated by Tax (fold change≥2.0, p< 0.05) (Continued)
FSTL3 follistatin-like 3 (secreted glycoprotein) 10272 2.2
GAB2 GRB2-associated binding protein 2 9846 2.2
PDLIM3 PDZ and LIM domain 3 27295 2.2
PMEPA1 prostate transmembrane protein, androgen induced 1 56937 2.2
SLC1A3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 6507 2.2
FNDC3B fibronectin type III domain containing 3B 64778 2.3
PHLDA3 pleckstrin homology-like domain, family A, member 3 23612 2.3
SLC25A4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 291 2.3
TPM4 tropomyosin 4 7171 2.3
DSE dermatan sulfate epimerase 29940 2.5
VEGFC vascular endothelial growth factor C 7424 2.5
CSTA cystatin A (stefin A) 1475 2.6
ZDHHC18 zinc finger, DHHC-type containing 18 84243 2.6
CDK2AP2 cyclin-dependent kinase 2 associated protein 2 10263 2.7
TIPARP TCDD-inducible poly(ADP-ribose) polymerase 25976 2.7
CSTA cystatin A (stefin A) 1475 2.8
TNFAIP2 tumor necrosis factor, alpha-induced protein 2 7127 2.8
PSD4 pleckstrin and Sec7 domain containing 4 23550 3.1
KRT17 keratin 17 3872 3.7
ARC activity-regulated cytoskeleton-associated protein 23237 5.4
LXN latexin 56925 5.5
TRIM31 tripartite motif-containing 31 11074 20.1
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with the induction of apoptosis, CARD10 and BCLAF1,
were downregulated by Tax. The majority of the genes
upregulated by Tax were involved in apoptosis. Further-
more, several of these genes also function in the immune
response (ADORA2A, CD70, FAS, BCL6, TNFRSF1B
and IL6). Interestingly, several highly upregulated genes,
such as IER3, TNFAIP3, BIRC3 and IL6, have both pro-
and anti-apoptotic functions. In contrast, the highly
upregulated gene, TNFRSF9, is pro-apoptotic only. TNF
and TNF receptor family genes were also found to be
upregulated by Tax in this study.
To confirm and extend the results of the microarray
experiments, expression of the pro-apoptotic and anti-
apoptotic genes regulated by Tax was measured by qRT-
PCR using specific primers. Genes upregulated in
the microarray were also upregulated in qRT-PCR
(Figure 2D), although there were small differences in the
levels measured by the two methods. For example, the
expression levels of BIRC3 and IL6 measured by qRT-
PCR were almost twice that measured by microarray
analysis, and the expression level of the apoptosis in-
ductor TNFRSF9 was more than three times higher by
qRT-PCR than by microarray. Despite these minordifferences, overall gene expression levels measured by
qRT-PCR were similar to those measured by microarray
analysis.
Visualizing the spatiotemporal dynamics of the regulation
of cell cycle progression and apoptosis by tax
To clarify whether Tax causes apoptosis independently
of its ability to induce G1 arrest, the spatiotemporal pat-
terns of cell cycle regulation in response to Tax expres-
sion were monitored in HeLa/Fucci2 cells [33]. This
system was chosen because it allows dual-color imaging,
in which G1-phase nuclei are labeled orange and S/G2/
M-phase nuclei are labeled green. A fluorescent Tax
vector was constructed that allows the identification
of Tax-expressing HeLa/Fucci2 cells. This vector con-
tained Tax, an internal ribosomal entry site (IRES), cyan
fluorescent protein (CFP), and a Flag sequence at the
3’ end of tax. The vector was expressed in HeLa cells, and
Tax-expressing cells were stained with an anti-Flag MAb
followed by an Alexa Fluor 594 secondary antibody (red).
As shown in Figure 3A, all Tax-expressing cells were
CFP-positive (blue).
HeLa/Fucci2 cells were plated on a glass coverslip,
transiently transfected with Tax-IRES-CFP or the CFP
Table 2 Genes downregulated by Tax (fold change≥ 2.0, p< 0.05)
Gene symbol Gene description Gene ID Fold change
Transcription/Translation/RNA processing
ANP32A Cerebellar leucine rich acidic nuclear protein (LANP) 8125 2.0
EID1 EP300 interacting inhibitor of differentiation 1 23741 2.0
PAIP1 poly(A) binding protein interacting protein 1 10605 2.0
RBM4 RNA binding motif protein 4 5936 2.0
SFRS7 splicing factor, arginine/serine-rich 7, 35 kDa 6432 2.0
SR140 U2-associated SR140 protein 23350 2.0
BCLAF1 BCL2-associated transcription factor 1 9774 2.1
IMPACT Impact homolog (mouse) 55364 2.3
LSM5 LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) 23658 2.3
MRPS14 mitochondrial ribosomal protein S14 63931 2.3
SUB1 SUB1 homolog (S. cerevisiae) 10923 2.3
ZNF623 zinc finger protein 623 9831 2.3
BRIP1 BRCA1 interacting protein C-terminal helicase 1 83990 2.4
TTF2 transcription termination factor, RNA polymerase II 8458 2.6
Signal transduction
PDE1A phosphodiesterase 1A, calmodulin-dependent 5136 2.0
PDE3A phosphodiesterase 3A, cGMP-inhibited 5139 2.0
PRKCI protein kinase C, iota 5584 2.1
SRI sorcin 6717 2.8
Immune response/Response to virus
DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 23586 2.2
IFI44 interferon-induced protein 44 10561 2.2
DDX60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 55601 3.0
IFIT3 interferon-induced protein with tetratricopeptide repeats 3 3437 4.1
IFIT2 interferon-induced protein with tetratricopeptide repeats 2 3433 4.4
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 3434 6.0
OASL 2'-5'-oligoadenylate synthetase-like 8638 6.4
Apoptosis
CARD10 caspase recruitment domain family, member 10 29775 2.0
BCLAF1 BCL2-associated transcription factor 1 9774 2.1
Cell cycle
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 4085 2.0
KIF11 kinesin family member 11 3832 2.1
NF2 neurofibromin 2 (merlin) 4771 2.1
SEP11 septin 11 55752 2.1
CENPF centromere protein F, 350/400 ka (mitosin) 1063 2.5
Regulation of cell proliferation
BMP2 bone morphogenetic protein 2 650 2.2
DAB2 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) 1601 2.4
FGF2 fibroblast growth factor 2 (basic) 2247 3.4
Cell signaling
PCSK1 proprotein convertase subtilisin/kexin type 1 5122 4.8
Cell adhesion
Arainga et al. BMC Genomics 2012, 13:275 Page 10 of 19
http://www.biomedcentral.com/1471-2164/13/275
Table 2 Genes downregulated by Tax (fold change≥ 2.0, p< 0.05) (Continued)
CD24 CD24 molecule 100133941 2.3
PKP2 plakophilin 2 5318 2.3
COL14A1 collagen, type XIV, alpha 1 7373 2.5
Nucleosome assembly
H2AFV H2A histone family, member V 94239 2.0
Transport
CNGB1 cyclic nucleotide gated channel beta 1 1258 2.0
SCNN1A sodium channel, nonvoltage-gated 1 alpha 6337 2.0
ANO2 anoctamin 2 57101 2.1
CHRNA9 cholinergic receptor, nicotinic, alpha 9 55584 2.2
SORBS1 sorbin and SH3 domain containing 1 10580 2.3
STEAP4 STEAP family member 4 79689 2.3
SRI sorcin 6717 2.6
Metabolic process
ACSL4 acyl-CoA synthetase long-chain family member 4 2182 2.0
Ubiquitin
FBXO3 F-box protein 3 26273 2.0
HERC6 hect domain and RLD 6 55008 2.1
DZIP3 DAZ interacting protein 3, zinc finger 9666 2.3
HERC5 hect domain and RLD 5 51191 4.8
Others/Unknown
NIP7 nuclear import 7 homolog (S. cerevisiae) 51388 2.0
PPL periplakin 5493 2.0
ADK adenosine kinase 132 2.1
DIO2 deiodinase, iodothyronine, type II 1734 2.1
PICALM phosphatidylinositol binding clathrin assembly protein 8301 2.1
METAP2 methionyl aminopeptidase 2 10988 2.2
HIP1R huntingtin interacting protein 1 related 9026 2.3
ERAP1 KIAA0525 protein 51752 2.4
DAB2 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) 1601 2.5
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http://www.biomedcentral.com/1471-2164/13/275control vector, and then incubated for 24 h. Next, fields
containing orange, green, and blue fluorescence were
selected and images were acquired using an Olympus
LCV110 Imaging System (Figure 3B and 3C). The prolif-
eration of control HeLa/Fucci2 cells was evidenced by
the fraction of cells at G1 phase with orange nuclei, the
fraction of cells at S/G2/M phase with green nuclei, and
the subsequent change in the fluorescence of these cells
(Figure 3B upper panel and 3D), which indicated that
the cells progressed normally through the cell cycle. At
24 h post-transfection, all HeLa/Fucci2 cells expressing
Tax-IRES-CFP, which resulted in blue fluorescence,
also had orange nuclei, indicating that they were in G1
phase (Figure 3B, lower panel). During the culture
period, HeLa/Fucci2 cells expressing Tax-IRES-CFP
did not progress to S/G2/M phase, as evidenced by thepresence of orange nuclei and the absence of green nu-
clei in Tax-expressing cells (Figure 3B). Additionally, a
marked decrease was observed in the proportion of
Tax-IRES-CFP-expressing cells in S/G2/M phase com-
pared with control cells expressing CFP alone
(Figure 3D), indicating that Tax arrests cells at the G1
phase of the cell cycle.
Interestingly, overexpression of Tax appeared to re-
duce the number of HeLa/Fucci2 cells in culture
(Figure 3E). Moreover, apoptosis was assessed by the ap-
pearance of rounded cells after an increase in the num-
ber of Tax-expressing cells at G1 phase, starting at 36 h
post-transfection (Figure 3B and 3C). At 72 h post trans-
fection, there was a notable reduction in the overall
number of cells, as well as in the percentage of Tax-
















































































































































Figure 2 Expression profile of genes involved in cell cycle regulation and apoptosis that were altered following the induction of Tax
protein. Heat maps showing the hierarchical clustering of genes involved in cell cycle regulation (A) and apoptosis (C) are shown for
Tax-expressing cells. The color scheme indicates the fold change in gene expression, with upregulated genes shown in orange/red and
downregulated genes shown in blue (with respect to baseline levels under control conditions (yellow)). qRT-PCR validation of the upregulated
genes associated with cell cycle regulation (B) and apoptosis (D). RNA from Tax-expressing cells and control cells was used to validate the
microarray data. The bars indicate the fold change in gene expression following Tax expression. Data were normalized to GAPDH mRNA. The
results represent the mean of two samples from one experiment.
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http://www.biomedcentral.com/1471-2164/13/275Expression kinetics of genes involved in cell cycle
regulation and apoptosis that are altered following
induction of tax protein
To analyze the correlation between the expression of
genes related to cell cycle regulation (IL8, SMAD3,
CDKN1A, GADD45A and GADD45B) and apoptosis
(IL6) (that are altered following the induction of Tax)
with the dynamics of cell cycle and apoptosis (shown in
Figure 3), total RNA was prepared at 12, 24, 36 and 48 h
after transfection of HeLa cells with Tax or a control
vector. Each RNA sample was then subjected to qRT-
PCR. As indicated in Figure 4, the expression levels of
SMAD3, GADD45A and GADD45B in Tax-transfected
cells began to increase from 6 h post-transfection and
reached a peak at 24 h, decreasing again by 36 h. In the
case of IL8, CDKN1A and IL6 in Tax-expressing cells,
the expression levels reached a peak at 24 h, decreased
at 36 h, and then increased again at 48 h.
The kinetics and results from time-lapse imaging
indicate that marked upregulation of IL8, SMAD3,
CDKN1A, GADD45A, GADD45B and IL6 at 24 h post-
transfection was well correlated with a notable reduction
in the number of Tax-expressing cells and an increase of
Tax-expressing cells in the G1 phase.
Discussion
This study used large-scale host cell gene profiling with
human cDNA microarrays and time-lapse imaging of
HeLa/Fucci2 cells to monitor the dynamics of Tax-
induced cell death. Three major conclusions can be
drawn from the data: (i) Tax induces cell cycle arrest at
the G1 phase in HeLa cells as assessed by flow cytome-
try. This result was confirmed by the accumulation of
hypo- and/or unphosphorylated form of Rb in Tax-
expressing cells. Moreover, analysis of Annexin V-
stained cells and caspase-3 activity clearly demonstrated
that Tax promotes apoptosis. Thus, a high level of
transiently-expressed Tax can arrest the cell cycle at the
G1 phase and induce apoptosis in HeLa cells. (ii) The
most interesting aspect of this study was visualizing the
morphological dynamics of Tax-induced cell death after
cell cycle arrest at the G1 phase. Time-lapse imaging of
HeLa/Fucci2 cells showed that Tax-induced apoptosis
was dependent on the ability of Tax to induce G1 arrest.
(iii) Microarray data revealed that Tax induced gene ex-
pression changes in HeLa cells; 17 Tax-dependent genes
were found to be related to cell cycle regulation and 23
to apoptosis (> 2.0-fold up- or downregulation). (iv)
The kinetics of gene expression identified that Tax-
induced changes in the expression of IL8, SMAD3,
CDKN1A, GADD45A, GADD45B and IL6 closely corre-
lated with the morphological changes of the cell cycle
and apoptosis observed by time-lapse imaging. Since
these genes are related not only to cell cycle regulationand apoptosis induction, but also to stress kinase path-
ways, the present study suggests that Tax may induce
apoptosis and cell cycle arrest by activating genes related
to stress-response signaling pathways.
Many studies show that the Tax oncoprotein acceler-
ates G1 progression [3,4,7-12] and is capable of stimulat-
ing anti-apoptotic signaling pathways [29,30,36,37]. In
contrast, the present study showed that Tax arrests cells
at G1, thereby inducing apoptosis. Our results consist
with previous results obtained using HeLa cells and
SupT1 cells [20,38]. There may be possible explanations
for how Tax induces cell cycle arrest and apoptosis. One
interesting finding from our microarray analysis was the
marked activation of stress kinase pathways induced
by Tax. In mammalian cells, two families of stress-
responsive MAPKs, c-Jun N-terminal kinase (JNK) and
p38, are activated by stimuli such as UV radiation, oxi-
dative stress and translation inhibitors, as well as by in-
flammatory cytokines, tumor necrosis factor α (TNFα),
and transforming growth factor β (TGFβ). These
signaling pathways promote apoptosis, cell survival, cell
cycle arrest, inflammation and differentiation [39,40].
Interestingly, microarray analysis revealed that genes
such as SMAD3 and SMAD4, which are the principal
intracellular effectors of the TGFβ family [41,42];
GADD45A and GADD45B, which are implicated as
stress sensors and activated by TGFβ in a SMAD-
dependent manner [43-45]; DUSP1, DUSP5, DUSP6 and
DUSP13, which are stress-inducible MAP kinase phos-
phatases [46]; MAP kinase kinase kinase 8 (MAP3K8)
[46]; JUN [46], which is the effector transcription factor
of the JNK pathway; and IL6, IL8 and FAS, which are in-
flammatory cytokines, were all upregulated by Tax.
These genes, expressed in response to Tax, are media-
tors of JNK and p38 activity. In addition, we found that
the kinetics of altered expression of several genes related
to pathways involving stress-responsive MAPKs were
closely correlated with the kinetics of the spatial and
temporal patterns of cell cycle dynamics analyzed in
time-lapse imaging. At 24 h post-transfection with
Tax expression vectors, the genes for IL8, SMAD3,
CDKN1A, GADD45A, GADD45B and IL6 were sig-
nificantly upregulated (Figure 4) and the number of
Tax-IRES-CFP-expressing cells were in G1 phase and
underwent apoptosis started to increase at same timing
(Figure 3). Thus, the present results suggest that Tax may
induce apoptosis and cell cycle arrest by activating several
genes related to stress-response signaling pathways. This
is supported by a recent publication showing that Tax,
along with the activation of a stress kinase, can induce
cell death [31]. Furthermore, the present findings consist
with those observed by previous microarray analysis stud-
ies of HTLV-1-infected T cells, which demonstrated that
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Figure 3 Time-lapse imaging of morphological changes in HeLa/Fucci2 cells after Tax-induced cell cycle arrest at G1 phase. (A) HeLa
cells were transfected with the pCAGGS-Tax-IRES-CFP vector or the control pCAGGS-IRES-CFP vector. At 24 h after transfection, cells were stained
with an anti-Flag MAb followed by an Alexa Fluor 594-conjugated secondary MAb and analyzed by confocal laser scanning microscopy (Olympus
FV1000). Cells showing red and blue fluorescence express Tax-Flag and CFP, respectively. (B and C) HeLa/Fucci2 cells were transfected with the
CAGGS-Tax-IRES-CFP vector or the control pCAGGS-IRES-CFP vector and monitored by time-lapse photography using the Olympus LCV110
Imaging System. One day after transfection, CFP-positive cells were selected and fluorescence and phase images were captured once every
15 min for 2 days. Cells showing orange or green fluorescence are in the G1 or S/G2/M phase of cell cycle, respectively. Apoptotic cells, which
show a rounded morphology, are marked by arrows. The populations of CFP-expressing cells at the G1 and S/G2/M phases (D and E, respectively)
were quantified using MetaMorph 7.7.4 software.
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involved in MAPK stress-response pathways [23]. Re-
cently, HTLV-1 Tax appeared indirectly to connect to cell
cycle proteins such as SMAD3, SMAD4, GADD45A and
GADD45B [47].
Our microarray analysis results identified one of the
genes upregulated by Tax as CDKN1A, which codes
p21CIP1/WAF1, known as Cdk inhibitor 1. Again, this is in
agreement with results from other microarray analyses
showing that HTLV-1 infection and Tax expression
upregulated p21CIP1/WAF1 in HTLV-1-infected T cells[23] and the human Jurkat T-cell line JPX-9, which ex-
press Tax under the control of an inducible promoter
[48]. Likewise, Tax has previously been shown to dra-
matically upregulate p21CIP1/WAF1 mRNA transcription
and stabilization of p21CIP1/WAF1 in HeLa cells [20,21].
Interestingly, only minimal p21/WAF1 promoter activity
appears to be induced by Tax [23]. It is also known that
basal levels of p21CIP1/WAF1 are required to promote
TGFβ-mediated cell cycle arrest, whereas a lack of
p21CIP1/WAF1 allows the induction of cell proliferation in
response to TGFβ [49]. Indeed, the loss of p21CIP1/WAF1
Figure 4 Expression kinetics of genes involved in cell cycle
regulation and apoptosis that were altered following induction
of Tax. HeLa cells were transiently transfected with a pCAGGS-Tax
Flag-tagged vector or the control pCAGGS vector. Total RNA was
prepared at 12, 24, 36 and 48 h after transfection and then each
RNA sample was subjected to qRT-PCR. The bars indicate the fold
change in the gene following Tax expression. Data were normalized
to GAPDH mRNA. The results represent the mean± standard
deviation (SD) of three samples from one experiment.
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and Tax-induced G1 arrest to be bypassed [20]. There-
fore, Tax may induce cell cycle arrest and apoptosis in
HeLa cells by up-regulating GADD45B, SMAD3 and
SMAD4 (which act downstream of TGFβ) in the pres-
ence of p21CIP1/WAF1 (which is activated by Tax).
In HTLV-1 infected T cell lines, upregulated p21CIP1/WAF1
may potentially function as an assembly factor for the
cyclin D2/cdk4 complex, and the p21/cyclin D2/cdk4
complex may not act as an inhibitory complex but in-
stead may allow the increased phosphorylation of Rb
and accelerated progression into S phase [50]. In the
present study, Tax-mediated G1 arrest occurred in
human papilloma virus type 18 (HPV-18)-transformed
HeLa cells, in which the Rb pathway was activated by
repression of HPV-18 E7 [51]. Indeed, in cells trans-
fected with the control vector, the majority of Rb was in
the hyperphosphorylated form ppRb (Figure 1E). By
contrast, an accumulation of hypo- and/or unpho-
sphorylated form pRb was observed in Tax-expressing
HeLa cells, which is in contrast to the results of study
showing that Tax increased the phosphorylation of Rb
family members [19]. Therefore, there is a strong possi-
bility that Tax-activated p21CIP1/WAF1 may function to
inhibit the cyclin D2/cdk4 complex, thereby inducing
cell cycle arrest.
Our microarray result also shows that Tax upregulated
the expression of BCL6 gene encodes a sequences-
specific transcriptional repressor by 2.7 fold. This sup-
ported by the findings in previous study [52], which
described that an interaction of Tax with the POZ do-
main of BCL6 enhances the repressive activity of BCL6
and increased the levels of apoptosis induced by BCL6
in osteosarcoma cells. The BCL6 POZ domain mediates
transcriptional repression by interacting with several
corepressors including silencing mediator for retinoid
and thyroid receptor and nuclear hormone receptor cor-
epressor, BCL6 corepressor together with many histone
deacetylases. BCL6 colocalizes with these corepressors
in punctate nuclear structures that have been identified
as sites of ongoing DNA replication. Interestingly, BCL6
appeared to recruite Tax into punctate nuclear structures
and significantly downregulate both basal and Tax-
induced NF-kB and long terminal repeat activation [52].
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cells may contribute to the silencing of viral gene ex-
pression and to the long clinical latency associated with
HTLV infection.
This study allows greater understanding of the bio-
logical events affected by HTLV-1 Tax, particularly the
regulation of cellular proliferation and apoptosis. Since
we found evidence of several similarities, as well as dif-
ferences, between Tax-expressing HeLa cells and HTLV
infection in T cell lines, we believe that the overexpres-
sion of Tax will be useful for preliminary studies on the
effects of HTLV infection in T cell lines. However, since
Zane et al. recently demonstrated that infected CD4+ T
cells in vivo are positively selected for cell cycling but
not cell death [53], our experimental approaches in
HeLa cells may not be reflective of normal physiology of
Tax or HTLV-1 in vivo infected cells. Therefore, further
detailed studies are required to define the direct and in-
direct effects of Tax-mediated cellular processes to gain
a better understanding of the contribution of Tax to
HTLV-1 pathogenesis in vivo.
Conclusion
The present study showed that Tax arrested cells at the
G1 phase of the cell cycle, thereby inducing apoptosis.
Taken together, the results demonstrate that Tax exerts
a significant impact on cellular factors that regulate the
cell cycle and the induction of apoptosis. Importantly, to
the best of our knowledge, this is the first study to high-
light the morphological dynamics of Tax-induced cell
death after cell cycle arrest at the G1 phase.
This overview can be extended to Tax-mediated sig-
naling, and further study of the interactions between
Tax and cellular factors will provide insights into the
mechanisms by which Tax regulates host cell behavior,
as well as the mechanisms underlying lymphoma induc-
tion and progression induced by HTLV-1.
Methods
Cell lines and transfections
Human cervical HeLa cells and Fucci2-expressing HeLa
cells (HeLa/Fucci2) [33] were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Invitrogen) supple-
mented with 10% heat-inactivated fetal bovine serum
(FBS) and 100 units/ml penicillin/streptomycin (Sigma).
Cells were transiently transfected with a Tax expression
vector, or a control vector, using Fugene HD (Roche)
according to the manufacturer’s instructions.
Plasmid construction
The HTLV-1 tax gene was amplified from the HTLV-1 in-
fectious molecular clone, K30 [54], using the primers
HTax-F (5’-3’, AACTCGAGGCCACCATGGCCCATTTC
CCAGGGTTTGGAC) and HTax-R (5’-3’, AAGCGGCCGCTCACTTGTCGTCATCGTCTTTGTAGTCGACTTCT
GTTTCTCGGAAATGTTTTTCACTGG). The underlined
sequences correspond to restriction enzyme sites specific
for XhoI and NotI, respectively. A Flag sequence was
included at the 3’ end of the tax gene. Full-length tax was
then cloned into the XhoI and NotI restriction sites in the
pCAGGS mammalian expression vector [55]. To generate
the pCAGGS-Tax-IRES-CFP vector and the pCAGGS-
IRES-CFP control vector, the IRES was amplified from the
pRetroX-IRES-ZsGreen1 vector (Clontech) and CFP was
amplified from the pCS2+ vector (Clontech). The IRES and
CFP sequences were then inserted into the pCAGGS con-
trol vector or a pCAGGS vector containing Flag-tagged
Tax. The vector pEGFP-N1 encodes a red-shifted variant of
wild-type GFP that was modified for brighter fluorescence
[56] and which was used as a reporter to identify trans-
fected cells by flow cytometry. The pSV-β-galactosidase
vector (Promega) encoding a bacterial β-galactosidase and
pRL-SV40 (Promega) encoding Renilla luciferase were used
to normalize the transfection efficiency. pGV-HL21
encodes five tandemly repeated 21 bp enhancers of HTLV-
1, each of which contain a CRE motif and pGV(−) and have
been previously decribed [57].
RNA extraction
HeLa cells were transiently transfected with Tax or the
control vector and incubated for 30 h. RNA from total
cell extracts was isolated using the RNeasy Mini Kit
(Qiagen) according to the manufacturer's instructions.
RNA was quantified using a spectrophotometer and
stored at −80°C. For gene chip analysis, the quality of
RNA was determined using the Agilent Bioanalyzer
(Agilent Technologies).
Microarray analysis
RNA samples were analyzed by microarray using the
GeneChip Human Genome U133A 2.0 Array (Affymetrix).
Microarray hybridization and fluorescence detection were
performed as described in the Affymetrix Gene-Chip
Expression Analysis Technical Manual. Microarray data
were deposited in NCBI’s Gene Expression Omnibus
and assigned GEO Series accession number GSE34750.
GeneSpring GX 11.0 software (Agilent Technologies) was
used to identify statistically significant differences in gene
expression between samples. For multiple measurements
to detect significantly upregulated and downregulated
genes, the Bonferroni correction was performed by adjust-
ing the significance level (p< 0.05). Fold changes in gene
expression, hierarchical clustering, and gene ontology
annotations were determined.
qRT-PCR
Total RNA was prepared using the RNeasy Mini Kit
(Qiagen) at 12, 24, 36 and 48 h after transfection with
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specific primers and OneStep SYBR Green PCR mix
(Takara) following the manufacturer’s instructions. The
qRT-PCR was performed using a 7500 Fast Real-time
PCR System (Applied Biosystems). All data were nor-
malized to GAPDH mRNA.
Immunoblot analysis
Transfected cells were lysed and proteins were sepa-
rated on 6%, 10%, or 17% SDS-polyacrylamide gels and
then transferred to a PVDF membrane (Immobilon-P,
Millipore Corp.) using a Trans-blot SD semi-dry transfer
cell (Bio-Rad). Following the transfer, the membranes
were blocked in 5% non-fat dry milk in PBS containing
0.1% Tween-20 for 1 h and then incubated with a 1:1000
dilution of primary antibody against Flag (M2, Sigma),
Rb (c-15, Santa Cruz Biotechnology), or actin (c-11, Santa
Cruz Biotechnology) for 1 h. The membranes were then
washed and incubated with anti-mouse, anti-rabbit, or
anti-goat horseradish peroxidase-conjugated secondary
antibodies (Jackson, ImmunoResearch) and developed
using the SuperSignal West Pico Chemiluminescent sub-
strate Kit (Pierce).
Immunofluorescence
Cells (1 x 105) were seeded onto 22 mm diameter cover-
slips in 24-well plates and incubated at 37°C for 24 h be-
fore transfection. Cells were transiently transfected with
either a Tax expression vector or a control vector using
the Fugene HD reagent (Roche). Twenty-four hours
later, the cells were washed twice with PBS, fixed in 3.7%
formaldehyde, permeabilized using 0.2% Triton X-100,
and stained with an anti-Flag MAb (M2, Sigma) followed
by an anti-mouse IgG1 antibody conjugated to Alexa
Fluor 488 or 494 (Molecular Probes). Subcellular
localization was analyzed by confocal laser scanning mi-
croscopy (FV1000, Olympus).
Luciferase assay
HeLa cells (1 x 105) were transfected with 1 μg of the re-
porter plasmid, pGV-HL21 (HTLV-1 enhancer) or pGV
(−), 0.3 μg of the reference plasmid, pRL-SV40, and
0.5 μg of the Tax expression vector. At 48 h after trans-
fection, cells were recovered and the activity of firefly
and Renilla luciferase was measured in the lysates as
previously described [58]. For each sample, firefly luci-
ferase activity (pGV-HL21) was normalized by reference
to Renilla luciferase activity (pRL-SV40).
Cell cycle analysis
HeLa cells (4 x 105) were incubated in a 6-well plate at
37°C for 24 h followed by co-transfection for 48 h with
2 μg of the Tax expression vector or the control vector
and 0.2 μg of the pEGFP-N1 vector. Cells were collectedand washed with PBS without Ca2+ and Mg2+ and then
fixed with 1% paraformaldehyde followed by 70% etha-
nol. After fixation, cells were washed twice with PBS,
treated with 200 μg/ml of RNase for 1 h at 37°C, and
stained with 50 μg/ml of PI. Fluorescence was analyzed
using a FACSCalibur (Becton-Dickinson) flow cytometer
and Cell Quest software (Becton-Dickinson). Samples
were gated to eliminate cells in which GFP emitted
strong fluorescence. The acquired FACS data were ana-
lyzed using ModFit LT software (Verity Software House).
Analysis of apoptosis
Flow cytometry was used to detect Annexin V-positive
apoptotic cells. Transfected cells were incubated for
48 h and then the cell monolayers were detached with
trypsin and ethylendiaminetetraacetic acid (EDTA),
washed twice in PBS, and re-suspended in binding buffer
(1 x 106 cells/ml). An aliquot of 1 x 105 cells was stained
with 7-AAD and Annexin V-PE (BD Biosciences) for
15 min at room temperature according to the manufac-
turer's instructions and then analyzed on a FACSCalibur
flow cytometer (BD Biosciences) with Cell Quest soft-
ware (BD Biosciences). Cells were considered to be in
the early stages of apoptosis if they showed staining for
Annexin V-PE but not 7-AAD. The double-positive
population was considered to be in the late stages of
apoptosis, or already dead.
Caspase-3 activity was measured using a caspase-
3/CPP32 fluorometric assay kit, according to the manu-
facturer's instructions. Briefly, transfected HeLa cells
were harvested, washed twice with PBS, and treated with
lysis buffer. Cell lysates were centrifuged at 15000 × g for
10 min at 4°C, supernatants were collected, and protein
concentrations were determined with the Pierce BCA
protein assay kit (Thermo Scientific). For each experi-
mental point, 50 μg of total protein extract was incu-
bated with the substrate for 2 h at 37°C. Caspase activity
was quantified spectrophotometrically at a wavelength of
405 nm using a multi-label counter (Model 1420, Wallac
Arvo, Perkin Elmer Life Sciences).
Imaging of cultured cells
HeLa/Fucci2 cells were transiently transfected with
Tax-IRES-CFP or the control vector and were subjected
to long-term, time-lapse imaging using a computer-
assisted fluorescence microscope (Olympus, LCV110)
equipped with an objective lens (Olympus, UAPO
40×/340 N.A. = 0.90), a halogen lamp, a red LED
(620 nm), a CCD camera (Olympus, DP30), differential
interference contrast (DIC) optical components, and
interference filters. For fluorescence imaging, the halogen
lamp was used with three filter cubes for observing
mCherry (orange), Venus (green), and CFP (blue) fluores-
cence. For DIC imaging, the red LED was used with a
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http://www.biomedcentral.com/1471-2164/13/275filter cube containing an analyzer. Image acquisition and
analysis were performed using MetaMorph 7.7.4 software
(Universal Imaging).
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